Joanne Chiu

1.3k total citations · 1 hit paper
52 papers, 516 citations indexed

About

Joanne Chiu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joanne Chiu has authored 52 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Joanne Chiu's work include HER2/EGFR in Cancer Research (15 papers), Advanced Breast Cancer Therapies (12 papers) and Lung Cancer Treatments and Mutations (9 papers). Joanne Chiu is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Advanced Breast Cancer Therapies (12 papers) and Lung Cancer Treatments and Mutations (9 papers). Joanne Chiu collaborates with scholars based in China, Hong Kong and United States. Joanne Chiu's co-authors include Thomas Yau, Roland Leung, Richard J. Epstein, Hilda Wong, Ava Kwong, Raymond Liang, Tan To Cheung, Charles Swanton, Vikki Tang and Brian Hung‐Hin Lang and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joanne Chiu

45 papers receiving 511 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

2024 53 citations Javier Cortés, Sara A. Hurvitz et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanne Chiu China	13	241	155	123	89	62	52	516
Lijun Xu China	13	196 0.8×	96 0.6×	156 1.3×	86 1.0×	24 0.4×	36	505
Renpin Chen China	14	120 0.5×	65 0.4×	177 1.4×	83 0.9×	86 1.4×	27	505
H.G. Beger Germany	8	240 1.0×	68 0.4×	151 1.2×	63 0.7×	166 2.7×	18	458
Yihe Yan China	14	138 0.6×	62 0.4×	167 1.4×	103 1.2×	42 0.7×	37	541
Fuxiang Yu China	12	81 0.3×	76 0.5×	196 1.6×	121 1.4×	101 1.6×	27	460
Takaaki Oba Japan	16	425 1.8×	85 0.5×	177 1.4×	73 0.8×	39 0.6×	45	716
Haoxuan Wu China	13	122 0.5×	101 0.7×	213 1.7×	115 1.3×	66 1.1×	29	438
Helin Feng China	15	130 0.5×	144 0.9×	238 1.9×	197 2.2×	79 1.3×	47	557
Alessio Degiovanni Italy	12	107 0.4×	85 0.5×	121 1.0×	70 0.8×	53 0.9×	23	345

Countries citing papers authored by Joanne Chiu

Since Specialization

Citations

This map shows the geographic impact of Joanne Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Chiu more than expected).

Fields of papers citing papers by Joanne Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Chiu. The network helps show where Joanne Chiu may publish in the future.

Co-authorship network of co-authors of Joanne Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Chiu. A scholar is included among the top collaborators of Joanne Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Chiu. Joanne Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cortés, Javier, Sara A. Hurvitz, Seock‐Ah Im, et al.. (2024). Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial. Nature Medicine. 30(8). 2208–2215. 53 indexed citations breakdown →

Luo, Yongfeng, Joanne Chiu, Hui Chen, et al.. (2024). Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts. eLife. 12.

Zhang, Qingyuan, Kunwei Shen, Quchang Ouyang, et al.. (2024). Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study. Therapeutic Advances in Medical Oncology. 16. 12731511–12731511. 2 indexed citations

Luo, Yongfeng, Joanne Chiu, Hui Chen, et al.. (2023). Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts. eLife. 12. 1 indexed citations

Chiu, Joanne, Soo Chin Lee, Jcm Ho, et al.. (2023). Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel. Drug Safety. 46(10). 927–949. 16 indexed citations

Chiu, Joanne, Fei Su, Norikazu Masuda, et al.. (2023). Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial. BMC Medicine. 21(1). 306–306. 13 indexed citations

Joshi, Rohit, Joanne Chiu, Ann Chen, et al.. (2023). A phase 2 randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): ELEVATE-TNBC.. Journal of Clinical Oncology. 41(16_suppl). TPS1130–TPS1130. 1 indexed citations

Michel, Loren S., Antonio Jimeno, Ammar Sukari, et al.. (2023). 859MO Sacituzumab govitecan (SG) in patients (pts) with relapsed/refractory (R/R) advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II TROPiCS-03 basket trial. Annals of Oncology. 34. S558–S558. 8 indexed citations

Li, Bryan, Thomas Yau, Roland Leung, et al.. (2021). Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers. Advances in Therapy. 38(12). 5752–5762.

10.

Leboeuf, Fabien, et al.. (2021). Repeatability of the Oxford Foot Model: Comparison of a team of assessors with different backgrounds and no prior experience of the Oxford Foot Model. Gait & Posture. 92. 191–198. 7 indexed citations

11.

Yap, Yoon Sim, Joanne Chiu, Yoshinori Ito, et al.. (2020). Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer Science. 111(9). 3313–3326. 10 indexed citations

12.

Iwata, Hiroji, Norikazu Masuda, Sung‐Bae Kim, et al.. (2019). Neratinib After Trastuzumab-Based Adjuvant Therapy in Patients from Asia with Early Stage HER2-Positive Breast Cancer. Future Oncology. 15(21). 2489–2501. 7 indexed citations

13.

Yau, Thomas, et al.. (2017). A phase 1 study of recombinant human arginase 1 (PEG-BCT- 100) in combination with capecitabine and oxaliplatin in advanced hepatocellular carcinoma patients. Annals of Oncology. 28. iii54–iii54. 3 indexed citations

14.

Lee, Victor, et al.. (2015). P-270 Regorafenib for metastatic colorectal cancer in community setting: a multicenter retrospective analysis in Hong Kong. Annals of Oncology. 26. iv79–iv79.

15.

Chiu, Joanne, Kelvin Chan, Eric X. Chen, Lillian L. Siu, & Albiruni R. Abdul Razak. (2015). Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT). Investigational New Drugs. 33(4). 895–900. 11 indexed citations

16.

Luo, Yongfeng, Elie El Agha, Gianluca Turcatel, et al.. (2015). Mesenchymal adenomatous polyposis coli plays critical and diverse roles in regulating lung development. BMC Biology. 13(1). 42–42. 16 indexed citations

17.

Chiu, Joanne, Sébastien J. Hotte, Christian Kollmannsberger, et al.. (2015). A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041). Investigational New Drugs. 34(1). 104–111. 15 indexed citations

18.

Wong, HM, Stanley C. K. Lau, Roland Leung, et al.. (2011). Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer. Medical Oncology. 29(3). 1536–1542. 16 indexed citations

19.

Chiu, Joanne, Thomas Yau, & Richard J. Epstein. (2008). Complications of traditional Chinese/herbal medicines (TCM)—a guide for perplexed oncologists and other cancer caregivers. Supportive Care in Cancer. 17(3). 231–240. 32 indexed citations

20.

Chiu, Joanne, et al.. (1998). Vasopressin opposes locomotor stimulation by ethanol, cocaine and amphetamine in mice. European Journal of Pharmacology. 355(1). 11–17. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact